Ying Lu

1.6k total citations
56 papers, 1.1k citations indexed

About

Ying Lu is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Ying Lu has authored 56 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Hematology and 12 papers in Oncology. Recurrent topics in Ying Lu's work include Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ying Lu is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Ying Lu collaborates with scholars based in China, United States and Canada. Ying Lu's co-authors include C.H. Arrowsmith, Frans A. A. Mulder, Ayeda Ayed, Lewis E. Kay, Gwan‐Su Yi, Sushil K. Thukral, Guoqiang Chen, Luc E. M. Marengère, Tak W. Mak and Louis-Martin Boucher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ying Lu

56 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Lu China 18 741 276 219 163 128 56 1.1k
Adrian Britschgi Switzerland 16 691 0.9× 383 1.4× 176 0.8× 117 0.7× 139 1.1× 22 1.1k
Apostolos Dimitromanolakis Canada 24 628 0.8× 308 1.1× 230 1.1× 58 0.4× 95 0.7× 37 1.4k
Norihiko Shiraishi Japan 19 1.2k 1.7× 350 1.3× 109 0.5× 397 2.4× 166 1.3× 62 1.9k
Ying Jiao China 14 492 0.7× 350 1.3× 229 1.0× 74 0.5× 196 1.5× 30 1.1k
Yongwei Zhang United States 22 1.2k 1.6× 529 1.9× 233 1.1× 37 0.2× 152 1.2× 52 1.6k
Weida Gong United States 23 1.5k 2.0× 371 1.3× 314 1.4× 115 0.7× 121 0.9× 42 2.0k
Misao Hachiya Japan 17 492 0.7× 247 0.9× 122 0.6× 76 0.5× 112 0.9× 33 899
Ashley Martin United Kingdom 16 696 0.9× 191 0.7× 125 0.6× 204 1.3× 185 1.4× 31 1.2k
Diane Wang United States 25 728 1.0× 662 2.4× 83 0.4× 44 0.3× 136 1.1× 102 2.2k
Panagiotis Pantazis United States 13 701 0.9× 470 1.7× 158 0.7× 46 0.3× 110 0.9× 35 1.1k

Countries citing papers authored by Ying Lu

Since Specialization
Citations

This map shows the geographic impact of Ying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Lu more than expected).

Fields of papers citing papers by Ying Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Lu. The network helps show where Ying Lu may publish in the future.

Co-authorship network of co-authors of Ying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Lu. A scholar is included among the top collaborators of Ying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Lu. Ying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Weihui, Ying Wang, Ying Lu, et al.. (2024). Reg4 deficiency aggravates pancreatitis by increasing mitochondrial cell death and fibrosis. Cell Death and Disease. 15(5). 348–348. 2 indexed citations
2.
Lu, Ying, et al.. (2024). Intestinal Goblet Cell-Expressed Reg4 Ameliorates Intestinal Inflammation Potentially by Restraining Pathogenic Escherichia coli Infection. Probiotics and Antimicrobial Proteins. 17(6). 4891–4910. 2 indexed citations
3.
Luo, Chen‐Hui, Lihong Hu, Xia Li, et al.. (2024). CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma. Nature Communications. 15(1). 10594–10594. 2 indexed citations
4.
Li, Xia, Xuehong Zhang, Qianqian Yin, et al.. (2023). Osimertinib Covalently Binds to CD34 and Eliminates Myeloid Leukemia Stem/Progenitor Cells. Cancer Research. 84(3). 479–492. 4 indexed citations
6.
Xiao, Yongtao, Yu Sun, Ying Lu, et al.. (2021). Loss function of Bcr mutation causes gastrointestinal dysmotility and brain developmental defects. Neurogastroenterology & Motility. 33(12). e14190–e14190. 1 indexed citations
8.
Liu, Xisheng, Xiao Peng, Qianlan Yao, et al.. (2021). Impaired AGO2/miR-185-3p/NRP1 axis promotes colorectal cancer metastasis. Cell Death and Disease. 12(4). 390–390. 30 indexed citations
9.
Luo, Yuxuan, Ying Lu, Bing Long, et al.. (2021). Blocking DNA Damage Repair May Be Involved in Stattic (STAT3 Inhibitor)-Induced FLT3-ITD AML Cell Apoptosis. Frontiers in Cell and Developmental Biology. 9. 637064–637064. 5 indexed citations
10.
Li, Xia, et al.. (2021). SUMOylation disassembles the tetrameric pyruvate kinase M2 to block myeloid differentiation of leukemia cells. Cell Death and Disease. 12(1). 101–101. 25 indexed citations
11.
Lu, Ying, Hui Li, Weiwei Li, et al.. (2020). Characterization of a G9 group A rotavirus reassortant strain detected in Jinzhou, China, in 2018–2019. Archives of Virology. 165(4). 977–983. 5 indexed citations
12.
Xiang, Siying, Jing Zhao, Ying Lu, et al.. (2019). Network pharmacology-based identification for therapeutic mechanism of Ling-Gui-Zhu-Gan decoction in the metabolic syndrome induced by antipsychotic drugs. Computers in Biology and Medicine. 110. 1–7. 24 indexed citations
13.
Lu, Ying, Xiangfu Liu, Ruifang Fan, et al.. (2016). Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function. Biomedicine & Pharmacotherapy. 84. 1551–1557. 23 indexed citations
14.
Lu, Ying, et al.. (2016). Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells. Journal of Translational Medicine. 14(1). 270–270. 25 indexed citations
15.
Jin, Wei‐Na, Ying Lu, Qinghua Li, et al.. (2014). Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways. The International Journal of Biochemistry & Cell Biology. 54. 111–121. 16 indexed citations
16.
Lu, Ying & Guoqiang Chen. (2011). Effector Caspases and Leukemia. International Journal of Cell Biology. 2011. 1–8. 19 indexed citations
17.
Li, Xi, Qiong Wang, Ying Lu, et al.. (2006). Leukemogenic AML1‐ETO fusion protein upregulates expression of connexin 43: The role in AML1‐ETO‐induced growth arrest in leukemic cells. Journal of Cellular Physiology. 208(3). 594–601. 28 indexed citations
19.
Ayed, Ayeda, Frans A. A. Mulder, Gwan‐Su Yi, et al.. (2001). Latent and active p53 are identical in conformation.. Nature Structural Biology. 8(9). 756–760. 233 indexed citations
20.
Boucher, Louis-Martin, Luc E. M. Marengère, Ying Lu, Sushil K. Thukral, & Tak W. Mak. (1997). Binding Sites of Cytoplasmic Effectors TRAF1, 2, and 3 on CD30 and Other Members of the TNF Receptor Superfamily. Biochemical and Biophysical Research Communications. 233(3). 592–600. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026